Founded in 2002, Nano-Ditech Corp specializes in the development and manufacture of high quality rapid immuno-diagnostic products to serve the point-of-care market place including medical professionals, physicians, clinical laboratories and hospitals. Nano-Ditech is proud to be among the few that have a track record for successfully developing test devices through the development of raw materials and obtaining US FDA and CE clearance. Nano-Ditechs unique techniques have enabled us to rapidly develop all classes of monoclonal antibodies for each of the illicit drugs and cardiac disease markers to be specifically used for the rapid assay. We aspire to be the global leader in the development and commercialization of cutting-edge rapid diagnostics technologies that improve patient outcomes and enhance healthcare efficiency. We are committed to driving innovation in the field of diagnostics, and we strive to create solutions that are accessible, reliable, and accurate. Our goal is to empower healthcare providers and patients with the tools they need to make informed decisions and achieve better health outcomes.